Výsledky vyhledávání - "Paolo Siviero"

Managing Risk and Uncertainty in Health Technology Introduction: The Role of Managed Entry Agreements

Autor: Panos Kanavos, Alessandra Ferrario, Giovanni Tafuri, Paolo Siviero

Publikováno v: Global Policy. 8:84-92

Managed entry agreements (MEAs) comprise a variety of instruments to reduce uncertainty arising from incomplete information on budget impact, cost-effectiveness, use in real life, and access to new therapies. MEAs have a number of advantages and limi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cdfca19911fa7e01ca1dac462a05bf65
https://doi.org/10.1111/1758-5899.12386

Zobrazit plný text záznamu

Performance-Based Risk-Sharing Arrangements-Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force

Autor: Johan L. Severens, Penny Mohr, Miguel Sleeper, Louis P. Garrison, Andrew Briggs, Adrian Towse, Gérard de Pouvourville, Jens Grueger, Paolo Siviero

Publikováno v: Value in Health, 16, 703-719. Elsevier Ltd.

There is a significant and growing interest among both payers and producers of medical products for agreements that involve a “pay-for-performance” or “risk-sharing” element. These payment schemes—called “performance-based risk-sharing ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cdb74d9f0615793194e11fa1ec52ab
https://pure.eur.nl/en/publications/284ba713-9d5d-475a-a7ae-cbc18142beff

Zobrazit plný text záznamu

Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers

Autor: P Russo, Paolo Siviero, F S Mennini, Guido Rasi

Publikováno v: Annals of oncology 21/10 (2010): 2081–2087.
info:cnr-pdr/source/autori:Russo P, Mennini FS, Siviero PD, Rasi G./titolo:Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers/doi:/rivista:Annals of oncology/anno:2010/pagina_da:2081/pagina_a:2087/intervallo_pagine:2081–2087/volume:21%2F10

AIM: The main purpose of this study was to identify each sequential phase followed by an oncology product, from European assessment until to patient access in each Italian region (IR). METHODS: A panel of oncology products approved by the European Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a49a3a8149538968e6fa44e01d28134
https://publications.cnr.it/doc/168570

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání